Neuro-AI and clinical intelligence
Validation, explainability, data quality and the use of AI across discovery, diagnosis, trials and decision support.
Hilton Singapore Orchard · July 12–14, 2027
Neuroscience, Neuro-AI and BCI conference for commercialization leaders.
NEURO-LOGIC 2027 is where precision neuroscience moves beyond promising research and into the decisions that determine adoption: evidence, regulation, infrastructure, investment, partnerships and market access.
Why this meeting exists
A neuroscience conference built around translation.
Scientific progress in neuroscience is accelerating, but successful translation depends on more than discovery alone. Teams must align clinical evidence, AI validation, regulatory pathways, data systems, reimbursement, capital and commercial strategy.
NEURO-LOGIC brings those connected questions into one executive-level forum. The summit is designed for people deciding which technologies advance, how they are validated, where they fit in care pathways and what is required to build durable neuroscience businesses.
Conference focus
Topics shaping precision neuroscience in 2027.
Brain-computer interfaces
Clinical utility, implantable and non-invasive platforms, regulation, reimbursement and routes to scaled adoption.
Precision therapeutics
Biomarkers, patient stratification, trial design and evidence strategies for targeted neurological interventions.
Data and infrastructure
Interoperability, neurological datasets, digital biomarkers, privacy and the systems required to deploy Neuro-AI responsibly.
Investment and partnerships
Capital strategy, pharma collaboration, licensing, corporate development and the milestones investors use to assess neurotechnology.
Commercialization and access
Market definition, health-system adoption, reimbursement, procurement and practical go-to-market choices.
Who should attend
The stakeholders needed to move neuroscience forward.
- Pharmaceutical and biotechnology neuroscience leaders
- Neuro-AI, BCI, neurotechnology and digital-health companies
- Clinical researchers, neurologists and translational scientists
- Regulatory, market-access and reimbursement professionals
- Investors, venture teams and corporate-development leaders
- Data, imaging, device, CRO and technology partners
Event details
NEURO-LOGIC 2027 at a glance.
DatesJuly 12–14, 2027
LocationHilton Singapore Orchard, Singapore
FormatExecutive conference, panels and curated networking
What kind of neuroscience conference is NEURO-LOGIC 2027?
NEURO-LOGIC is a business-focused precision neuroscience summit connecting science with commercialization, regulation, investment, infrastructure, market access and partnership strategy.
Does the programme cover Neuro-AI and brain-computer interfaces?
Yes. Neuro-AI, brain-computer interfaces, neurotechnology, digital biomarkers, data infrastructure and precision therapeutics are central parts of the conference scope.
Who should attend the neuroscience summit?
The summit is designed for neuroscience and pharmaceutical leaders, Neuro-AI and BCI companies, investors, regulators, clinical researchers, technology partners and commercial decision-makers.
From topic to working relationships
Meet the people shaping the precision neuroscience market.
Explore registration options or review how NEURO-LOGIC structures networking and deal access.